Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cancer Research|August 30, 2018
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8<sup>+</sup> T Cells in Head and Neck CancerSri Krishna, Peaches Ulrich, Eric Wilson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2019
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal CancerGypsyamber D'Souza, Gwendolyn Clemens, Tanya Troy, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
The prognostic significance of human papilloma virus in sinonasal squamous cell carcinomaEmily Schlussel Markovic, Kathryn E Marqueen, Kunal K Sindhu, et al.
Cancers|June 10, 2022
Management of Older Adults with Locally Advanced Head and Neck CancerDaniel R Dickstein, Eric J Lehrer, Kristin Hsieh, et al.
The Laryngoscope|June 18, 2022
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral TongueBrianna M Jones, Dillan F Villavisanis, Eric J Lehrer, et al.
Current Oncology (Toronto, Ont.)|January 22, 2024
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 PandemicJulie R Bloom, Carlos Rodriguez-Russo, Kristin Hsieh, et al.
Head & Neck|January 21, 2021
Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus eraAndrew W Smith, Matthew Gallitto, Eric J Lehrer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Advances in Radiation Oncology|May 23, 2024
Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell CarcinomaKristin Hsieh, Alexandra Elena Hotca, Daniel R Dickstein, et al.
Journal for Immunotherapy of Cancer|September 8, 2025
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancerCaroline Even, Kevin J Harrington, Erminia Massarelli, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|August 30, 2018
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8<sup>+</sup> T Cells in Head and Neck CancerSri Krishna, Peaches Ulrich, Eric Wilson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2019
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal CancerGypsyamber D'Souza, Gwendolyn Clemens, Tanya Troy, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
The prognostic significance of human papilloma virus in sinonasal squamous cell carcinomaEmily Schlussel Markovic, Kathryn E Marqueen, Kunal K Sindhu, et al.
Cancers|June 10, 2022
Management of Older Adults with Locally Advanced Head and Neck CancerDaniel R Dickstein, Eric J Lehrer, Kristin Hsieh, et al.
The Laryngoscope|June 18, 2022
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral TongueBrianna M Jones, Dillan F Villavisanis, Eric J Lehrer, et al.
Current Oncology (Toronto, Ont.)|January 22, 2024
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 PandemicJulie R Bloom, Carlos Rodriguez-Russo, Kristin Hsieh, et al.
Head & Neck|January 21, 2021
Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus eraAndrew W Smith, Matthew Gallitto, Eric J Lehrer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Advances in Radiation Oncology|May 23, 2024
Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell CarcinomaKristin Hsieh, Alexandra Elena Hotca, Daniel R Dickstein, et al.
Journal for Immunotherapy of Cancer|September 8, 2025
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancerCaroline Even, Kevin J Harrington, Erminia Massarelli, et al.
Pageof 10